What hinders congenital ectopia lentis patients' follow-up visits? A qualitative study

Jianqiang Lin, Ni Gong, Qianzhong Cao, Yijing Zhou, Yitingxue Cai, Guangming Jin, Charlotte Aimee Young, Jing Yang, Yiyao Wang, Danying Zheng, Jianqiang Lin, Ni Gong, Qianzhong Cao, Yijing Zhou, Yitingxue Cai, Guangming Jin, Charlotte Aimee Young, Jing Yang, Yiyao Wang, Danying Zheng

Abstract

Objectives: The aim of our study is to give insight into congenital ectopia lentis (CEL) patients' care-seeking behaviour and explore the factors affecting their follow-up visits.

Design: Cross-sectional study; in-depth and face-to-face semistructured interview.

Setting: A large-scale ophthalmology hospital in China.

Participants: 35 patients with CEL and their parents from May 2017 to August 2017.

Main outcome measures: Themes and categories. The interviews were audio-recorded, transcribed verbatim, coded and analysed using grounded theory. Data collection was closed when new themes did not emerge in subsequent dialogues.

Results: The factors affecting the timely visits included insufficient awareness of CEL, shame on hereditary disease, lack of effective doctor-patient communication, lack of reliable information online and daily stressors.

Conclusion: Continuing medical education of severe and rare disease, reforming the pattern of medical education, constructing an interactive platform of the disease on the internet and improving healthcare policy are effective ways to improve the diagnosis and treatment status of CEL in China.

Keywords: congenital heart disease; health policy; medical education & training; paediatric ophthalmology; qualitative research.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Fuchs J, Rosenberg T. Congenital ectopia lentis. A Danish national survey. Acta Ophthalmol Scand 1998;76:20–6. 10.1034/j.1600-0420.1998.760105.x
    1. Sadiq MA, Vanderveen D. Genetics of ectopia lentis. Semin Ophthalmol 2013;28:313–20. 10.3109/08820538.2013.825276
    1. Ho NCY, Tran JR, Bektas A. Marfan's syndrome. Lancet 2005;366:1978–81. 10.1016/S0140-6736(05)66995-4
    1. Tinkle BT, Saal HM, Committee on genetics . Health supervision for children with Marfan syndrome. Pediatrics 2013;132:e1059–72. 10.1542/peds.2013-2063
    1. Loeys BL, Dietz HC, Braverman AC, et al. . The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010;47:476–85. 10.1136/jmg.2009.072785
    1. Hoffmann BA, Rybczynski M, Rostock T, et al. . Prospective risk stratification of sudden cardiac death in Marfan's syndrome. Int J Cardiol 2013;167:2539–45. 10.1016/j.ijcard.2012.06.036
    1. Miyahara S, Okita Y. Overview of current surgical strategies for aortic disease in patients with Marfan syndrome. Surg Today 2016;46:1006–18. 10.1007/s00595-015-1278-0
    1. Blankart CR, Milstein R, Rybczynski M, et al. . Economic and care considerations of Marfan syndrome. Expert Rev Pharmacoecon Outcomes Res 2016;16:591–8. 10.1080/14737167.2016.1240619
    1. von Kodolitsch Y, De Backer J, Schüler H, et al. . Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome. Appl Clin Genet 2015;8:137–55. 10.2147/TACG.S60472
    1. Kainulainen K, Pulkkinen L, Savolainen A, et al. . Location on chromosome 15 of the gene defect causing Marfan syndrome. N Engl J Med 1990;323:935–9. 10.1056/NEJM199010043231402
    1. Groth KA, Stochholm K, Hove H, et al. . Aortic events in a nationwide Marfan syndrome cohort. Clin Res Cardiol 2017;106:105–12. 10.1007/s00392-016-1028-3
    1. China Development Brief China rare disease survey report in 2018. Available: [Accessed 28 Feb 2018].
    1. Malterud K. Qualitative research: Standards, challenges, and guidelines. Lancet 2001;358:483–8. 10.1016/S0140-6736(01)05627-6
    1. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007;19:349–57. 10.1093/intqhc/mzm042
    1. Radke RM, Baumgartner H. Diagnosis and treatment of Marfan syndrome: an update. Heart 2014;100:1382–91. 10.1136/heartjnl-2013-304709
    1. Chinese health and family planning statistical Yearbook in 2017. Available: [Accessed 1 Sep 2017].
    1. Bao Y, Fan G, Zou D, et al. . Patient experience with outpatient encounters at public hospitals in Shanghai: examining different aspects of physician services and implications of overcrowding. PLoS One 2017;12:e0171684 10.1371/journal.pone.0171684
    1. Kluge E-HW, Competence KEH. Competence, capacity, and informed consent: beyond the cognitive-competence model. Can J Aging 2005;24:295–304. 10.1353/cja.2005.0077
    1. Song P, Tang W. Emphasizing humanities in medical education: promoting the integration of medical scientific spirit and medical humanistic spirit. Biosci Trends 2017;11:128–33. 10.5582/bst.2017.01092
    1. Wang J-B, Guo JJ, Yang L, et al. . Rare diseases and legislation in China. Lancet 2010;375:708–9. 10.1016/S0140-6736(10)60240-1
    1. Marfan World Available: 10.1016/S0140-6736(10)60240-1
    1. The Marfan Foundation Available:
    1. Achelrod D, Blankart CR, Linder R, et al. . The economic impact of Marfan syndrome: a non-experimental, retrospective, population-based matched cohort study. Orphanet J Rare Dis 2014;9:90 10.1186/1750-1172-9-90

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner